Intra-serotype variation of Streptococcus pneumoniae capsule and its quantification

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Streptococcus pneumoniae (Spn) is a major cause of respiratory and invasive diseases.
• Spn utilizes a capsular polysaccharide (CPS) to evade immune responses, with over 100 serotypes identified.
• Current Spn vaccines target CPS, but their effectiveness is limited by bacterial heterogeneity and capsule variation.

Purpose of the Study:

• To challenge the assumption of conserved capsule size within Spn serotypes.
• To develop and validate standardized, accessible methods for quantifying Spn capsulation.
• To investigate intra-serotype variations in capsule amount and thickness.

Main Methods:

• Modification of immunoblotting for CPS quantification in bacterial lysates.
• Adaptation of light microscopy for assessing capsule thickness.
• Evaluation of modified methods' reproducibility and accessibility.

Main Results:

• Significant differences in both CPS amount and capsule thickness were observed among clinical isolates of the same serotype.
• Quantification of CPS amount and capsule thickness correlated with immune serum effectiveness in opsonophagocytic killing assays.
• Limited intra-strain correlation was found between CPS production levels and capsule thickness.

Conclusions:

• Intra-serotype capsulation in Spn is not a conserved feature, contrary to common assumptions.
• Standardized quantification of capsule amount and thickness is crucial for Spn research and vaccine development.
• Variability in Spn capsule production may affect the reliability of standardized vaccine efficacy tests.